News Website

Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach - Frontiers

Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach Frontiers

Published: April 10, 2025, 3:24 p.m.

Read Full Article

Deciphering the tumor-immune interplay in endometrial carcinoma - MSN

Deciphering the tumor-immune interplay in endometrial carcinoma MSN

Published: March 11, 2025, 12:39 p.m.

Read Full Article

Deciphering the tumor-immune interplay in endometrial carcinoma - News-Medical.Net

Deciphering the tumor-immune interplay in endometrial carcinoma News-Medical.Net

Published: March 11, 2025, 5:53 a.m.

Read Full Article

Unveiling the Role of Tumor-Infiltrating Immune Cells in Endometrial Carcinoma - EIN News

Unveiling the Role of Tumor-Infiltrating Immune Cells in Endometrial Carcinoma EIN News

Published: March 10, 2025, 8:15 p.m.

Read Full Article

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer Frontiers

Published: March 4, 2025, 1:24 p.m.

Read Full Article

Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer - Cureus

Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer Cureus

Published: Feb. 28, 2025, 6:36 p.m.

Read Full Article

Researchers in Oregon are slowing down cancer by remotely cooking tumors - Oregon Public Broadcasting

Researchers in Oregon are slowing down cancer by remotely cooking tumors Oregon Public Broadcasting

Published: Feb. 28, 2025, 2 p.m.

Read Full Article

Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact? - Medpage Today

Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact? Medpage Today

Published: Feb. 19, 2025, 5:18 p.m.

Read Full Article

Intramural, Extra-endometrial Epithelial Tumor of the Uterine Corpus Associated With Adenomyosis: A Case Report of Clear Cell Carcinoma - Cureus

Intramural, Extra-endometrial Epithelial Tumor of the Uterine Corpus Associated With Adenomyosis: A Case Report of Clear Cell Carcinoma Cureus

Published: Feb. 17, 2025, 12:24 p.m.

Read Full Article

(PDF) The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors - ResearchGate

(PDF) The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors ResearchGate

Published: Feb. 14, 2025, 3:13 a.m.

Read Full Article

Latest Articles

Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach - Frontiers

Deciphering the tumor-immune interplay in endometrial carcinoma - MSN

Deciphering the tumor-immune interplay in endometrial carcinoma - News-Medical.Net

Unveiling the Role of Tumor-Infiltrating Immune Cells in Endometrial Carcinoma - EIN News

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer - Cureus

Researchers in Oregon are slowing down cancer by remotely cooking tumors - Oregon Public Broadcasting

Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact? - Medpage Today

Intramural, Extra-endometrial Epithelial Tumor of the Uterine Corpus Associated With Adenomyosis: A Case Report of Clear Cell Carcinoma - Cureus

(PDF) The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors - ResearchGate

Subscribe to Our Newsletter